

House
File
2413
-
Introduced


HOUSE
FILE
2413


BY
COMMITTEE
ON
PUBLIC
SAFETY


(SUCCESSOR
TO
HSB
609)


A
BILL
FOR


An
Act
relating
to
controlled
substances,
including
amending
1


the
controlled
substance
schedules,
removing
certain
2


references
to
marijuana,
making
penalties
applicable,
and
3


including
effective
date
provisions.
4


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
5


TLSB
5331HV
(1)
88


ss/rh



H.F.
2413


Section
1.
Section
124.201A,
Code
2020,
is
amended
by
1


striking
the
section
and
inserting
in
lieu
thereof
the
2


following:
3


124.201A
Cannabis-derived
products
——
rules.
4


1.
If
a
cannabis-derived
investigational
product
approved
5


as
a
prescription
drug
medication
by
the
United
States
food
6


and
drug
administration
is
added
to
the
federal
schedule
7


of
controlled
substances
by
the
federal
drug
enforcement
8


administration
and
notice
of
the
addition
is
given
to
the
9


board,
the
board
shall
similarly
add
the
prescription
drug
10


medication
in
the
schedule
of
controlled
substances
under
this
11


chapter.
12


2.
If
a
cannabis-derived
product
approved
as
a
13


prescription
drug
medication
by
the
United
States
food
and
14


drug
administration
is
eliminated
from
or
revised
in
the
15


federal
schedule
of
controlled
substances
by
the
federal
drug
16


enforcement
administration
and
notice
of
the
elimination
or
17


revision
is
given
to
the
board,
the
board
shall
similarly
18


eliminate
or
revise
the
prescription
drug
medication
in
the
19


schedule
of
controlled
substances
under
this
chapter.
20


3.
The
board
shall
adopt
rules
pursuant
to
chapter
17A
21


to
administer
this
section.
The
board
may
adopt
rules
on
an
22


emergency
basis
as
provided
in
section
17A.4,
subsection
3,
and
23


section
17A.5,
subsection
2,
to
administer
this
section,
and
24


the
rules
shall
be
effective
immediately
upon
filing
unless
25


a
later
date
is
specified
in
the
rules.
Any
emergency
rules
26


adopted
in
accordance
with
this
section
shall
also
be
published
27


as
a
notice
of
intended
action
as
provided
in
section
17A.4,
28


subsection
1.
29


4.
Any
cannabis-derived
investigational
product
or
30


cannabis-derived
product
approved
as
a
prescription
drug
31


medication
by
the
United
States
food
and
drug
administration
32


shall
not
be
considered
marijuana
or
cannabimimetic
agents,
33


both
as
defined
in
section
124.204,
tetrahydrocannabinols
34


as
used
in
section
124.204,
subsection
4,
paragraph
“u”
,
35


-1-


LSB
5331HV
(1)
88


ss/rh
1/
7



H.F.
2413


unnumbered
paragraph
1,
or
hemp
as
defined
in
section
204.2.
1


Sec.
2.
Section
124.204,
subsection
2,
Code
2020,
is
amended
2


by
adding
the
following
new
paragraph:
3


NEW
PARAGRAPH


.
be.
MT-45
(1-cyclohexyl-4-(1,2-
4


diphenylethyl)piperazine).
5


Sec.
3.
Section
124.204,
subsection
4,
paragraph
m,
Code
6


2020,
is
amended
to
read
as
follows:
7


m.
Marijuana
,
except
as
otherwise
provided
by
rules
of
the
8


board
for
medicinal
purposes


.
9


Sec.
4.
Section
124.204,
subsection
4,
paragraph
u,
10


unnumbered
paragraph
1,
Code
2020,
is
amended
to
read
as
11


follows:
12


Tetrahydrocannabinols,
except
as
otherwise
provided


13


by
rules
of
the
board
for
medicinal
purposes,


meaning
14


tetrahydrocannabinols
naturally
contained
in
a
plant
of
15


the
genus
Cannabis
(Cannabis
plant)
as
well
as
synthetic
16


equivalents
of
the
substances
contained
in
the
Cannabis
plant,
17


or
in
the
resinous
extractives
of
such
plant,
and
synthetic
18


substances,
derivatives,
and
their
isomers
with
similar
19


chemical
structure
and
pharmacological
activity
to
those
20


substances
contained
in
the
plant,
such
as
the
following:
21


Sec.
5.
Section
124.204,
subsection
6,
paragraph
i,
Code
22


2020,
is
amended
by
adding
the
following
new
subparagraphs:
23


NEW
SUBPARAGRAPH


.
(27)
1-(1,3-benzodioxol-5-yl)-2-
24


(ethylamino)-pentan-1-one.
Other
names:
N-ethylpentylone
or
25


ephylone.
26


NEW
SUBPARAGRAPH
.
(28)
N-Ethylhexedrone,
its
optical,
27


positional,
and
geometric
isomers,
salts
and
salts
of
isomers
28


(Other
name:
2-(ethylamino)-1-phenylhexan-1-one).
29


NEW
SUBPARAGRAPH


.
(29)
alpha-Pyrrolidinohexanophenone,
its
30


optical,
positional,
and
geometric
isomers,
salts
and
salts
of
31


isomers
(Other
names:
α
-PHP;
alpha-pyrrolidinohexiophenone;
32


1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one).
33


NEW
SUBPARAGRAPH


.
(30)
4-Methyl-alpha-
34


ethylaminopentiophenone,
its
optical,
positional,
and
geometric
35


-2-


LSB
5331HV
(1)
88


ss/rh
2/
7












H.F.
2413


isomers,
salts
and
salts
of
isomers
(Other
names:
4—MEAP;
1


2-(ethylamino)-1-(4-methylphenyl)pentan-1-one).
2


NEW
SUBPARAGRAPH


.
(31)
4’-Methyl-alpha-
3


pyrrolidinohexiophenone,
its
optical,
positional,
and
4


geometric
isomers,
salts
and
salts
of
isomers
(Other
5


names:
MPHP;
4’-methyl-alpha-pyrrolidinohexanophenone;
6


1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one).
7


NEW
SUBPARAGRAPH
.
(32)
alpha-Pyrrolidinoheptaphenone,
8


its
optical,
positional,
and
geometic
isomers,
9


salts
and
salts
of
isomers
(Other
names:
PV8;
10


1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one).
11


NEW
SUBPARAGRAPH


.
(33)
4’-Chloro-alpha-
12


pyrrolidinovalerophenone,
its
optical,
positional,
and
13


geometric
isomers,
salts
and
salts
of
isomers
(Other
names:
14


4-chloro-
α
-PVP;
4’-chloro-alpha-pyrrolidinopentiophenone;
15


1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one).
16


Sec.
6.
Section
124.204,
subsection
7,
Code
2020,
is
amended
17


by
striking
the
subsection.
18


Sec.
7.
Section
124.204,
subsection
9,
Code
2020,
is
amended
19


by
adding
the
following
new
paragraphs:
20


NEW
PARAGRAPH


.
af.
N-(1-phenethylpiperidin-4-yl)-N-
21


phenylcyclopropanecarboxamide,
its
isomers,
esters,
ethers,
22


salts
and
salts
of
isomers,
esters,
and
ethers.
Other
name:
23


cyclopropyl
fentanyl.
24


NEW
PARAGRAPH


.
ag.
N-(1-phenethylpiperidin-4-yl)-N-
25


phenylpentanamide,
its
isomers,
esters,
ethers,
salts
and
salts
26


of
isomers,
esters
and
ethers.
Other
name:
valeryl
fentanyl.
27


NEW
PARAGRAPH
.
ah.
N-(4-fluorophenyl)-N-(1-
28


phenethylpiperidin-4-yl)butyramide,
its
isomers,
esters,
29


ethers,
salts
and
salts
of
isomers,
esters,
and
ethers.
Other


30


name:
para-fluorobutyryl
fentanyl.
31


NEW
PARAGRAPH


.
ai.
N-(4-methoxyphenyl)-N-
32


(1-phenethylpiperidin-4-yl)butryamide,
its
isomers,
esters,
33


ethers,
salts
and
salts
of
isomers,
esters,
and
ethers.
Other


34


name:
para-methyoxybutyryl
fentanyl.
35


-3-


LSB
5331HV
(1)
88


ss/rh
3/
7










H.F.
2413


NEW
PARAGRAPH
.
aj.
N-(4-chlorophenyl)-N-(1-
1


phenethylpiperidin-4-yl)isobutryramide,
its
isomers,
esters,
2


ethers,
salts
and
salts
of
isomers,
esters,
and
ethers.
Other
3


name:
para-chloroisobutyryl
fentanyl.
4


NEW
PARAGRAPH
.
ak.
N-(1-phenethylpiperidin-4-yl)-
5


N-phenylisobutyramide,
its
isomers,
esters,
ethers,
salts
and
6


salts
of
isomers,
esters,
and
ethers.
Other
name:
isobutyryl
7


fentanyl.
8


NEW
PARAGRAPH


.
al.
N-(1-phenethylpiperidin-4-yl)-
9


N-phenylcyclopentanecarboxamide,
its
isomers,
esters,
ethers,
10


salts
and
salts
of
isomers,
esters,
and
ethers.
Other
name:
11


cyclopentyl
fentanyl.
12


NEW
PARAGRAPH


.
am.
N-(2-fluorophenyl)-2-methoxy-N-
13


(1-phenethylpiperidin-4-yl)acetamide,
its
isomers,
esters,
14


ethers,
salts
and
salts
of
isomers,
esters,
and
ethers.
Other
15


name:
ocfentanil.
16


NEW
PARAGRAPH


.
an.
Fentanyl-related
substances,
their
17


isomers,
esters,
ethers,
salts
and
salts
of
isomers,
esters
18


and
ethers.
“Fentanyl-related
substance”
means
any
substance
19


not
otherwise
listed
under
this
schedule
or
another
schedule,
20


and
for
which
no
exemption
or
approval
is
in
effect
under
21


section
505
of
the
federal
Food,
Drug,
and
Cosmetic
Act
that
22


is
structurally
related
to
fentanyl
by
one
or
more
of
the
23


following
modifications:
24


(1)
Replacement
of
the
phenyl
portion
of
the
phenethyl
group
25


by
any
monocycle,
whether
or
not
further
substituted
in
or
on
26


the
monocycle.
27


(2)
Substitution
in
or
on
the
phenethyl
group
with
alkyl,
28


alkenyl,
alkoxyl,
hydroxyl,
halo,
haloalkyl,
amino,
or
nitro
29


groups.
30


(3)
Substitution
in
or
on
the
piperidine
ring
with
alkyl,
31


alkenyl,
alkoxyl,
ester,
ether,
hydroxyl,
halo,
haloalkyl,
32


amino,
or
nitro
groups.
33


(4)
Replacement
of
the
aniline
ring
with
any
aromatic
34


monocycle
whether
or
not
further
substituted
in
or
on
the
35


-4-


LSB
5331HV
(1)
88


ss/rh
4/
7








H.F.
2413


aromatic
monocycle.
1


(5)
Replacement
of
the
N
-propionyl
group
by
another
acyl
2


group.
3


NEW
PARAGRAPH


.
ao.
Naphthalen-1-yl
1-(5-fluoropentyl)-
4


1
H
-indole-3-carboxylate.
Other
names:
NM2201
or
CBL2201.
5


NEW
PARAGRAPH
.
ap.
N
-(1-amino-3-methyl-1-oxobutan-
6


2-yl)-1-(5-fluoropentyl)-1
H
-indazole-3-carboxamide.
Other
7


name:
5F-AB-PINACA.
8


NEW
PARAGRAPH


.
aq.
1-(4-cyanobutyl)-
N
-(2-phenylpropan-
9


2-yl)-1
H
-indazole-3-carboxamide.
Other
names:
10


4-CN-CUMYL-BUTINACA,
4-cyano-CUMYL-BUTINACA,
4-CN-CUMYL
11


BINACA,
CUMYL-4CN-BINACA,
or
SGT-78.
12


NEW
PARAGRAPH


.
ar.
Methyl
2-(1-(cyclohexylmethyl)-1
H
-
13


indole-3-carboxamido)-3-methylbutanoate.
Other
names:
14


MMB-CHMICA
or
AMB-CHMICA.
15


NEW
PARAGRAPH


.
as.
1-(5-fluoropentyl)-
N
-(2-
16


phenylpropan-2-yl)-1
H
-pyrrolo[2,3-b]pyridine-3-carboxamide.
17


Other
name:
5F-CUMYL-P7AICA.
18


NEW
PARAGRAPH


.
at.
Ethyl
2-(1-(5-fluoropentyl)-1H-
19


indazole-3-carboxamido)-3,3-dimethylbutanoate,
its
optical,
20


positional,
and
geometric
isomers,
salts
and
salts
of
isomers
21


(other
name:
5F-EDMB-PINACA).
22


NEW
PARAGRAPH


.
au.
Methyl
2-(1-(5-fluoropentyl)-1H-indole-
23


3-carboxamido)-3,3-dimethylbutanoate,
its
optical,
positional,
24


and
geometric
isomers,
salts
and
salts
of
isomers
(other
name:
25


5F-MDMB-PICA).
26


NEW
PARAGRAPH
.
av.
N-(adamantan-1-yl)-1-(4-fluorobenzyl)-
27


1H-indazole-3-carboxamide,
its
optical,
positional,
and
28


geometric
isomers,
salts
and
salts
of
isomers
(other
names:
29


FUB-AKB48,
FUB-APINACA,
AKB48
N-(4-FLUOROBENZYL)).
30


NEW
PARAGRAPH


.
aw.
1-(5-fluoropentyl)-N-(2-
31


phenylpropan-2-yl)-1H-indazole-3-carboxamide,
its
optical,
32


positional,
and
geometric
isomers,
salts
and
salts
of
isomers
33


(other
names:
5F-CUMYL-PINACA,
SGT-25).
34


NEW
PARAGRAPH


.
ax.
(1-(4-fluorobenzyl)-1H-
35


-5-


LSB
5331HV
(1)
88


ss/rh
5/
7













H.F.
2413


indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)
methanone,
its
1


optical,
positional,
and
geometric
isomers,
salts
and
salts
of
2


isomers
(other
name:
FUB-144).
3


Sec.
8.
Section
124.206,
subsection
7,
paragraph
a,
Code
4


2020,
is
amended
by
striking
the
paragraph.
5


Sec.
9.
Section
124.208,
subsection
3,
paragraph
c,
Code
6


2020,
is
amended
to
read
as
follows:
7


c.
Any
substance
which
contains
any
quantity
of
a
derivative
8


of
barbituric
acid
or
any
salt
thereof
including
but
not


9


limited
to
Fioricet
.
10


Sec.
10.
Section
124.210,
subsection
3,
Code
2020,
is
11


amended
by
adding
the
following
new
paragraph:
12


NEW
PARAGRAPH


.
bd.
Brexanolone.
13


Sec.
11.
Section
124.210,
subsection
6,
Code
2020,
is
14


amended
by
adding
the
following
new
paragraph:
15


NEW
PARAGRAPH


.
m.
Solriamfetol
(2-amino-3-phenylpropyl
16


carbamate;
benzenepropanol,
beta-amino-,
carbamate
(ester).
17


Sec.
12.
Section
124.212,
Code
2020,
is
amended
by
adding
18


the
following
new
subsection:
19


NEW
SUBSECTION


.
6.
Approved
cannabidiol
drugs.
A
20


drug
product
in
finished
dosage
formulation
that
21


has
been
approved
by
the
United
States
food
and
22


drug
administration
that
contains
cannabidiol
23


(2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-
24


pentyl-1,3-benzenediol)
derived
from
cannabis
and
no
more
than
25


0.1
percent
(w/w)
residual
tetrahydrocannabinols.
26


Sec.
13.
EFFECTIVE
DATE.
This
Act,
being
deemed
of
27


immediate
importance,
takes
effect
upon
enactment.
28


EXPLANATION
29


The
inclusion
of
this
explanation
does
not
constitute
agreement
with
30


the
explanation’s
substance
by
the
members
of
the
general
assembly.
31


This
bill
relates
to
controlled
substances.
32


The
bill
allows
the
board
of
pharmacy
to
change
the
scheduled
33


status
of
cannabis-derived
products
and
cannabis-derived
34


investigational
products
based
on
scheduling
decisions
of
the
35


-6-


LSB
5331HV
(1)
88


ss/rh
6/
7








H.F.
2413


United
States
food
and
drug
administration
and
the
federal
1


drug
enforcement
administration
in
the
federal
schedule
of
2


controlled
substances.
3


The
bill
classifies
nine
synthetic
opioids,
one
opioid
4


analgesic,
ten
synthetic
cannabinoids,
and
seven
synthetic
5


cathinones
as
schedule
I
controlled
substances
under
the
Iowa
6


uniform
controlled
substances
Act
(Act).
The
bill
classifies
7


all
products
which
contain
derivatives
of
barbituric
acid
8


(butalbital)
as
schedule
III
controlled
substances
under
the
9


Act,
subject
to
reporting
to
the
prescription
monitoring
10


program,
and
classifies
one
central
nervous
system
depressant
11


and
one
central
nervous
system
stimulant
as
schedule
IV
12


controlled
substances
under
the
Act.
The
bill
classifies
any
13


United
States
food
and
drug
administration-approved
product
14


containing
cannabidiol
that
contains
no
more
than
0.1
percent
15


tetrahydrocannabinols
as
a
schedule
V
controlled
substance
16


under
the
Act.
17


The
bill
strikes
language
referring
to
medical
marijuana
18


programs
of
the
board
of
pharmacy.
19


The
bill
is
effective
upon
enactment.
20


-7-


LSB
5331HV
(1)
88


ss/rh
7/
7

